This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. Jama. 2016;315(15):1624–1645.
Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26(9):958–964.
Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care—a qualitative study. J Pain 2014;15(11):1148–1155.
Morasco BJ, Smith N, Dobscha SK, Deyo RA, Hyde S, Yarborough BJH. Outcomes of prescription opioid dose escalation for chronic pain: Results from a prospective cohort study. Pain (in press)
Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Morasco BJ. Setting Expectations, Following Orders, Safety, and Standardization: Clinicians’ Strategies to Guide Difficult Conversations About Opioid Prescribing. J Gen Intern Med 2019:1–7.
We would like to thank Stephanie Hyde for research assistance with this project.
The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs, the National Institute on Drug Abuse or the Agency for Healthcare Research and Quality.
Conflict of Interest
Research reported in this manuscript was supported by grant 034083 from the National Institute on Drug Abuse of the National Institutes of Health. The work was also supported by resources from the VA Health Services Research and Development-funded Center to Improve Veteran Involvement in Care at the VA Portland Health Care System (CIN 13-404). Dr. Wyse’s time was also supported by grant number K12HS026370 from the Agency for Healthcare Research and Quality. No author reports having any potential conflict of interest with this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wyse, J., Simmons, A., Ramachandran, B. et al. “I Don’t Mind Doing What It Takes to be Safe.” Patient Perspectives of Urine Drug Testing for Pain. J GEN INTERN MED (2020). https://doi.org/10.1007/s11606-020-05688-3
- urine drug testing
- long-term opioid therapy
- chronic pain
- primary care